All Trading Information are 15 minutes delayed
chart  EGX30  13,776.85  0.82 % chart   EGX70  603.65  0.81 % Traded Value (M)   394.78    Traded Volume (M)   70.67   98 21 48 167
Medinet Nasr Housing   1.37 %  chart 5.92  chart  ELSWEDY ELECTRIC   2.09 %  chart 14.19  chart  Pioneers Holding   0.64 %  chart 6.25  chart  Alexandria Mineral Oils Company   4.58 %  chart 4.57  chart  Arab Cotton Ginning   1.55 %  chart 1.768  chart  Egyptian Kuwaiti Holding   2.72 %  chart 1.474  chart  Oriental Weavers   1.28 %  chart 9.47  chart  Arabia Investments Holding   0.18 %  chart 0.568  chart  Juhayna Food Industries   0 %  chart 11.5  chart  Telecom Egypt   1 %  chart 13.15  chart  Sarwa Capital Holding   0 %  chart 5.99  chart  Emaar Misr for Development   0.32 %  chart 3.16  chart  Eastern Company   0.68 %  chart 16.28  chart  Orascom Investment Holding   0.19 %  chart 0.522  chart  Egyptian Iron & Steel   0.97 %  chart 3.12  chart  Heliopolis Housing   0.48 %  chart 21.11  chart  Egyptian Financial Group-Hermes Holding Company   1.38 %  chart 16.19  chart  Egyptian Chemical Industries (Kima)   0 %  chart 4.93  chart  T M G Holding   0.67 %  chart 10.5  chart  Arab Co. for Asset Management And Development   1.33 %  chart 2.29  chart  Egyptian for Tourism Resorts   1.14 %  chart 1.86  chart  Cairo For Investment And Real Estate Development   1 %  chart 11.11  chart  Palm Hills Development Company   1.24 %  chart 2.45  chart  Orascom Development Egypt   0.81 %  chart 6.24  chart  Six of October Development & Investment (SODIC)   -0.22 %  chart 13.47  chart  Ezz Steel   2.82 %  chart 12.02  chart  Global Telecom Holding   0.43 %  chart 4.68  chart  Commercial International Bank (Egypt)   0.23 %  chart 69.84  chart  Citadel Capital - Common Shares   0.89 %  chart 3.39  chart  GB AUTO   0 %  chart 4  chart 

RIVA PHARMA (RIVA.CA) Reports 3 Months Results (NILEX) Financial Results - 5/15/2019 2:12 PMArabic

Company Name : RIVA PHARMA
ISIN Code : EGS384N2C016
Currency : $
F/S Period : From 01/01/2019 To 31/03/2019
Net Loss : 187,817
F/S Period: From 01/01/2018 To 31/03/2018
Net Comparative Profit : 148,134
Audit Status : Reviewed
Source : RIVA PHARMA


Market is Closed